SVB Leerink Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: SVB Leerink
Rating: 2.7
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at SVB Leerink. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by SVB Leerink.

Company	Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price
BOLT Bolt Biotherapeutics	5/12/2023	Upgraded by	SVB Leerink	Analyst D. Graybosch	Market Perform -> Outperform		Low
ARWR Arrowhead Pharmaceuticals	5/12/2023	Downgraded by	SVB Leerink	Analyst M. Foroohar	Outperform -> Market Perform		Low
TRHC Tabula Rasa HealthCare	5/10/2023	Upgraded by	SVB Leerink	Analyst S. Davis	Market Perform -> Outperform		Low
DHR Danaher	5/1/2023	Reiterated by	SVB Leerink	Analyst P. Souda	Outperform		Low
PRTA Prothena	4/24/2023	Reiterated by	SVB Leerink	Analyst R. Li	Outperform		Low
GNFT Genfit	4/14/2023	Reiterated by	SVB Leerink	Analyst T. Smith	Outperform		Low

CNTB Connect Biopharma	4/12/2023	Reiterated by	SVB Leerink	Analyst T. Smith	Outperform		Low
ARWR Arrowhead Pharmaceuticals	4/12/2023	Upgraded by	SVB Leerink	Analyst M. Foroohar	Market Perform -> Outperform		Low
CORT Corcept Therapeutics	4/11/2023	Reiterated by	SVB Leerink	Analyst R. Ruiz	Market Perform	$25.00	Low
PRDS Pardes Biosciences	4/4/2023	Downgraded by	SVB Leerink	Analyst R. Ruiz	Outperform -> Market Perform	$9.00 -> $2.00	Low
ACLX Arcellx	3/30/2023	Target Raised by	SVB Leerink		Outperform	$35.00 -> $39.00	Low
ABT Abbott Laboratories	3/31/2023	Target Raised by	SVB Leerink		Market Perform	$90.00 -> $102.00	Low
REGN Regeneron Pharmaceuticals	3/27/2023	Upgraded by	SVB Leerink	Analyst D. Risinger	Market Perform -> Outperform		Low
RAIN Rain Oncology	3/21/2023	Reiterated by	SVB Leerink	Analyst F. Khurshid	Outperform	$11.00	Low
PTCT PTC Therapeutics	3/17/2023	Reiterated by	SVB Leerink	Analyst J. Schwartz	Market Perform	$48.00	Low
CNTA Centessa Pharmaceuticals	3/17/2023	Reiterated by	SVB Leerink	Analyst D. Risinger	Outperform	$6.00	Low
HALO Halozyme Therapeutics	3/16/2023	Downgraded by	SVB Leerink	Analyst D. Risinger	Outperform -> Market Perform	$42.00	Low
DBTX Decibel Therapeutics	3/15/2023	Downgraded by	SVB Leerink	Analyst M. Foroohar	Outperform -> Market Perform	$7.00 -> $2.00	Low
MORF Morphic	3/8/2023	Target Raised by	SVB Leerink		Outperform	$45.00 -> $56.00	Low
ICPT Intercept Pharmaceuticals	3/3/2023	Target Raised by	SVB Leerink		Market Perform	$17.00 -> $18.00	Low
ARGX argenx	3/3/2023	Target Raised by	SVB Leerink		Outperform	$430.00 -> $435.00	Low
GPCR Structure Therapeutics	2/28/2023	Reiterated by	SVB Leerink	Analyst D. Risinger	Outperform		Low
CGEN Compugen	2/28/2023	Reiterated by	SVB Leerink	Analyst D. Graybosch	Outperform		Low
IRON Disc Medicine Opco	2/28/2023	Reiterated by	SVB Leerink	Analyst T. Smith	Outperform	$36.00	Low
XNCR Xencor	2/23/2023	Reiterated by	SVB Leerink	Analyst J. Chang	Outperform		Low
MRNA Moderna	2/24/2023	Downgraded by	SVB Leerink	Analyst M. Foroohar	Market Perform -> Underperform	$111.00 -> $93.00	Low
NKTR Nektar Therapeutics	2/24/2023	Target Lowered by	SVB Leerink		Market Perform	$5.00 -> $3.00	N/A
BPMC Blueprint Medicines	2/24/2023	Target Lowered by	SVB Leerink		Market Perform	$45.00 -> $38.00	Low
IONS Ionis Pharmaceuticals	2/23/2023	Target Lowered by	SVB Leerink		Market Perform	$34.00 -> $27.00	Low
TDOC Teladoc Health	2/23/2023	Upgraded by	SVB Leerink	Analyst S. Davis	Market Perform -> Outperform	$34.00	Low
ABBV AbbVie	2/10/2023	Upgraded by	SVB Leerink	Analyst D. Risinger	Underperform -> Market Perform	$135.00 -> $153.00	Low
ENTA Enanta Pharmaceuticals	2/9/2023	Reiterated by	SVB Leerink		Market Perform	$49.00	Low
CBAY CymaBay Therapeutics	2/8/2023	Target Raised by	SVB Leerink		Outperform	$10.00 -> $12.00	Low
CNTB Connect Biopharma	2/8/2023	Target Lowered by	SVB Leerink		Outperform	$9.00 -> $7.00	Low
EQ Equillium	2/8/2023	Target Lowered by	SVB Leerink		Outperform	$12.00 -> $7.00	Low
CI The Cigna Group	2/8/2023	Target Raised by	SVB Leerink		Market Perform	$309.00 -> $335.00	Low
PINC Premier	2/8/2023	Target Lowered by	SVB Leerink		Outperform	$46.00 -> $42.00	Low
ILMN Illumina	2/8/2023	Target Raised by	SVB Leerink	Analyst P. Souda	Outperform	$249.00 -> $250.00	Low
VRTX Vertex Pharmaceuticals	2/8/2023	Target Lowered by	SVB Leerink		Outperform	$374.00 -> $365.00	Low
INCY Incyte	2/8/2023	Reiterated by	SVB Leerink		Underperform	$63.00	Low

DCPH Deciphera Pharmaceuticals	2/7/2023	Target Raised by	SVB Leerink		Outperform	$28.00 -> $30.00	Low
GMAB Genmab A/S	2/6/2023	Target Raised by	SVB Leerink		Market Perform	$33.00 -> $36.00	Low
FDMT 4D Molecular Therapeutics	2/6/2023	Target Lowered by	SVB Leerink	Analyst M. Foroohar	Market Perform	$15.00 -> $14.00	Low
IMVT Immunovant	2/6/2023	Target Raised by	SVB Leerink		Outperform	$14.00 -> $21.00	Low
SGEN Seagen	2/6/2023	Downgraded by	SVB Leerink	Analyst Andrew Berens	Outperform -> Market Perform	$162.00 -> $141.00	Low
REGN Regeneron Pharmaceuticals	2/6/2023	Target Raised by	SVB Leerink	Analyst D. Risinger	Market Perform	$770.00 -> $834.00	Low
GILD Gilead Sciences	2/3/2023	Target Raised by	SVB Leerink	Analyst D. Risinger	Market Perform	$81.00 -> $91.00	Low
TECH Bio-Techne	2/3/2023	Target Lowered by	SVB Leerink		Outperform	$125.00 -> $110.00	Low
BMRN BioMarin Pharmaceutical	2/3/2023	Target Raised by	SVB Leerink		Outperform	$122.00 -> $130.00	Low
IONS Ionis Pharmaceuticals	2/3/2023	Target Raised by	SVB Leerink		Market Perform	$33.00 -> $34.00	Low
MRK Merck & Co., Inc.	2/3/2023	Target Raised by	SVB Leerink		Outperform	$120.00 -> $122.00	Low
KALV KalVista Pharmaceuticals	2/3/2023	Target Lowered by	SVB Leerink		Outperform	$30.00 -> $20.00	Low
TMO Thermo Fisher Scientific	2/2/2023	Target Raised by	SVB Leerink		Outperform	$620.00 -> $630.00	Low
HOLX Hologic	2/2/2023	Target Raised by	SVB Leerink		Outperform	$90.00 -> $93.00	Low
AMGN Amgen	2/2/2023	Target Lowered by	SVB Leerink		Market Perform	$282.00 -> $267.00	Low
PFE Pfizer	2/1/2023	Target Lowered by	SVB Leerink	Analyst David Risinger	Market Perform	$49.00 -> $48.00	Low
OPRX OptimizeRx	1/27/2023	Reiterated by	SVB Leerink	Analyst S. Davis	Outperform		Low
OMCL Omnicell	1/27/2023	Reiterated by	SVB Leerink	Analyst S. Davis	Market Perform		Low
IQV IQVIA	1/27/2023	Reiterated by	SVB Leerink	Analyst S. Davis	Outperform		Low
CPSI Computer Programs and Systems	1/27/2023	Reiterated by	SVB Leerink	Analyst S. Davis	Outperform		Low
DNLI Denali Therapeutics	1/30/2023	Reiterated by	SVB Leerink	Analyst M. Goodman	Outperform	$50.00	Low
AVIR Atea Pharmaceuticals	1/27/2023	Target Lowered by	SVB Leerink		Market Perform	$8.00 -> $6.00	Low
ENTA Enanta Pharmaceuticals	1/27/2023	Target Lowered by	SVB Leerink		Market Perform	$50.00 -> $49.00	Low
PRDS Pardes Biosciences	1/27/2023	Target Lowered by	SVB Leerink		Outperform	$12.00 -> $9.00	Low
SCPH scPharmaceuticals	1/27/2023	Target Raised by	SVB Leerink	Analyst R. Ruiz	Outperform	$12.00 -> $13.00	Low
VIR Vir Biotechnology	1/27/2023	Target Lowered by	SVB Leerink	Analyst R. Ruiz	Outperform	$45.00 -> $43.00	Low
XERS Xeris Biopharma	1/27/2023	Target Lowered by	SVB Leerink		Outperform	$6.00 -> $5.00	Low
ELV Elevance Health	1/26/2023	Reiterated by	SVB Leerink	Analyst W. Mayo	Outperform	$580.00	Low
PLRX Pliant Therapeutics	1/24/2023	Target Raised by	SVB Leerink		Outperform	$33.00 -> $45.00	Low
BHVN Biohaven	1/24/2023	Reiterated by	SVB Leerink	Analyst M. Goodman	Outperform	$24.00	Low
MRK Merck & Co., Inc.	1/23/2023	Target Raised by	SVB Leerink		Outperform	$112.00 -> $120.00	Low
MRNS Marinus Pharmaceuticals	1/23/2023	Target Lowered by	SVB Leerink		Outperform	$27.00 -> $23.00	Low
RLMD Relmada Therapeutics	1/23/2023	Target Lowered by	SVB Leerink		Outperform	$42.00 -> $10.00	Low
ALNY Alnylam Pharmaceuticals	1/23/2023	Target Lowered by	SVB Leerink		Market Perform	$144.00 -> $143.00	Low
ALVR AlloVir	1/23/2023	Target Lowered by	SVB Leerink		Outperform	$25.00 -> $19.00	Low
BBIO BridgeBio Pharma	1/23/2023	Target Lowered by	SVB Leerink		Outperform	$23.00 -> $19.00	Low
BEAM Beam Therapeutics	1/23/2023	Target Lowered by	SVB Leerink		Outperform	$81.00 -> $77.00	Low
BLUE bluebird bio	1/23/2023	Target Lowered by	SVB Leerink		Market Perform	$9.00 -> $8.00	Low
DBTX Decibel Therapeutics	1/23/2023	Target Lowered by	SVB Leerink		Outperform	$10.00 -> $7.00	Low
EDIT Editas Medicine	1/23/2023	Target Raised by	SVB Leerink	Analyst R. Bienkowski	Market Perform	$6.00 -> $7.00	Low
IONS Ionis Pharmaceuticals	1/23/2023	Target Raised by	SVB Leerink		Market Perform	$32.00 -> $33.00	Low
NTLA Intellia Therapeutics	1/23/2023	Target Lowered by	SVB Leerink		Outperform	$86.00 -> $84.00	Low
RCKT Rocket Pharmaceuticals	1/23/2023	Target Lowered by	SVB Leerink		Outperform	$50.00 -> $49.00	Low
RGNX REGENXBIO	1/23/2023	Target Lowered by	SVB Leerink		Market Perform	$15.00 -> $14.00	Low
RXRX Recursion Pharmaceuticals	1/23/2023	Target Lowered by	SVB Leerink		Market Perform	$9.00 -> $8.00	Low
SRPT Sarepta Therapeutics	1/20/2023	Reiterated by	SVB Leerink		Outperform	$160.00	Low
ZYME Zymeworks	1/20/2023	Target Raised by	SVB Leerink	Analyst A. Berens	Market Perform	$8.00 -> $10.00	Low
SGEN Seagen	1/20/2023	Target Raised by	SVB Leerink	Analyst Andrew Berens	Outperform	$160.00 -> $162.00	Low
BGNE BeiGene	1/20/2023	Target Raised by	SVB Leerink		Outperform	$236.00 -> $300.00	Low
JNJ Johnson & Johnson	1/20/2023	Target Lowered by	SVB Leerink		Outperform	$194.00 -> $186.00	Low

MRNA Moderna	1/18/2023	Target Raised by	SVB Leerink	Analyst M. Foroohar	Market Perform	$102.00 -> $111.00	Low
EOLS Evolus	1/19/2023	Target Raised by	SVB Leerink		Outperform	$18.00 -> $20.00	Low
VRTX Vertex Pharmaceuticals	1/17/2023	Upgraded by	SVB Leerink		Market Perform -> Outperform	$374.00	Low
EXAS Exact Sciences	1/12/2023	Target Raised by	SVB Leerink		Outperform	$70.00 -> $75.00	Low
HOLX Hologic	1/12/2023	Target Raised by	SVB Leerink		Outperform	$85.00 -> $90.00	Low
HALO Halozyme Therapeutics	1/11/2023	Target Lowered by	SVB Leerink		Outperform	$62.00 -> $61.00	Low
MIRM Mirum Pharmaceuticals	1/10/2023	Target Lowered by	SVB Leerink		Outperform	$50.00 -> $39.00	Low
EDIT Editas Medicine	1/10/2023	Target Lowered by	SVB Leerink	Analyst R. Bienkowski	Market Perform	$7.00 -> $6.00	Low
KPTI Karyopharm Therapeutics	1/10/2023	Target Lowered by	SVB Leerink		Market Perform	$6.00 -> $5.00	Low
TSVT 2seventy bio	1/10/2023	Target Lowered by	SVB Leerink		Outperform	$41.00 -> $34.00	Low
VRDN Viridian Therapeutics	1/9/2023	Target Raised by	SVB Leerink		Outperform	$40.00 -> $45.00	Low
BLUE bluebird bio	1/6/2023	Target Raised by	SVB Leerink		Market Perform	$8.00 -> $9.00	Low
EXAS Exact Sciences	1/6/2023	Target Raised by	SVB Leerink		Outperform	$60.00 -> $70.00	Low
HOLX Hologic	1/6/2023	Target Raised by	SVB Leerink		Outperform	$78.00 -> $85.00	Low
A Agilent Technologies	1/6/2023	Target Raised by	SVB Leerink		Outperform	$160.00 -> $170.00	Low
ABCL AbCellera Biologics	1/6/2023	Target Lowered by	SVB Leerink		Outperform	$20.00 -> $18.00	Low
MASS 908 Devices	1/6/2023	Target Lowered by	SVB Leerink		Outperform	$25.00 -> $20.00	Low
RGEN Repligen	1/6/2023	Target Lowered by	SVB Leerink		Outperform	$230.00 -> $200.00	Low
TMO Thermo Fisher Scientific	1/6/2023	Target Raised by	SVB Leerink		Outperform	$555.00 -> $620.00	Low
WAT Waters	1/6/2023	Target Raised by	SVB Leerink		Market Perform	$320.00 -> $352.00	Low
FATE Fate Therapeutics	1/6/2023	Target Lowered by	SVB Leerink		Outperform	$62.00 -> $10.00	N/A
IPSC Century Therapeutics	1/6/2023	Target Lowered by	SVB Leerink		Outperform	$20.00 -> $14.00	Low
GRPH Graphite Bio	1/6/2023	Downgraded by	SVB Leerink	Analyst M. Foroohar	Outperform -> Market Perform	$11.00 -> $2.00	Low
AMED Amedisys	1/5/2023	Target Lowered by	SVB Leerink		Market Perform	$96.00 -> $85.00	Low
COGT Cogent Biosciences	1/5/2023	Target Raised by	SVB Leerink		Outperform	$18.00 -> $20.00	Low
PGNY Progyny	1/5/2023	Reiterated by	SVB Leerink	Analyst S. Davis	Outperform -> Market Perform	$59.00 -> $34.00	Low
PHR Phreesia	1/5/2023	Target Raised by	SVB Leerink	Analyst S. Davis	Outperform	$34.00 -> $39.00	Low
DCPH Deciphera Pharmaceuticals	1/4/2023	Target Raised by	SVB Leerink		Outperform	$25.00 -> $28.00	Low
AMTI Applied Molecular Transport	12/27/2022	Reiterated by	SVB Leerink		Outperform -> Market Perform		Low
AMGN Amgen	12/22/2022	Target Raised by	SVB Leerink		Market Perform	$256.00 -> $282.00	Low
RCKT Rocket Pharmaceuticals	12/22/2022	Target Lowered by	SVB Leerink		Outperform	$54.00 -> $50.00	Low
MDGL Madrigal Pharmaceuticals	12/20/2022	Target Raised by	SVB Leerink		Outperform	$145.00 -> $315.00	Low
NAMS NewAmsterdam Pharma	12/20/2022	Initiated by	SVB Leerink	Analyst R. Ruiz	Outperform	$19.00	Low
PCVX Vaxcyte	12/16/2022	Reiterated by	SVB Leerink	Analyst D. Risinger	Outperform	$60.00	Low
AXLA Axcella Health	12/16/2022	Reiterated by	SVB Leerink		Outperform -> Market Perform	$6.00 -> $2.00	Low
HCA HCA Healthcare	12/16/2022	Target Raised by	SVB Leerink		Outperform	$238.00 -> $286.00	Low
LLY Eli Lilly and	12/16/2022	Target Raised by	SVB Leerink		Outperform	$384.00 -> $410.00	Low
ROIV Roivant Sciences	12/19/2022	Target Raised by	SVB Leerink		Outperform	$8.00 -> $10.00	Low
KYMR Kymera Therapeutics	12/15/2022	Target Raised by	SVB Leerink	Analyst M. Kratky	Market Perform	$26.00 -> $31.00	Low
WVE Wave Life Sciences	12/14/2022	Target Raised by	SVB Leerink	Analyst M. Foroohar	Market Perform	$2.00 -> $7.00	Low
MRTX Mirati Therapeutics	12/14/2022	Target Lowered by	SVB Leerink		Outperform	$85.00 -> $75.00	Low
MIRM Mirum Pharmaceuticals	12/14/2022	Target Raised by	SVB Leerink		Outperform	$49.00 -> $50.00	Low
MRNA Moderna	12/13/2022	Target Raised by	SVB Leerink	Analyst M. Foroohar	Market Perform	$101.00 -> $102.00	Low
NRIX Nurix Therapeutics	12/13/2022	Target Lowered by	SVB Leerink		Outperform	$37.00 -> $28.00	Low
SPRY ARS Pharmaceuticals	12/13/2022	Initiated by	SVB Leerink	Analyst Roanna Ruiz	Outperform	$14.00	Low
HZNP Horizon Therapeutics Public	12/13/2022	Downgraded by	SVB Leerink	Analyst D. Risinger	Outperform -> Market Perform	$88.00 -> $116.50	Low
FATE Fate Therapeutics	12/13/2022	Target Lowered by	SVB Leerink		Outperform	$64.00 -> $62.00	Low
BGNE BeiGene	12/12/2022	Target Raised by	SVB Leerink		Outperform	$210.00 -> $236.00	Low
AFMD Affimed	12/12/2022	Target Lowered by	SVB Leerink		Outperform	$10.00 -> $6.00	Low
DSGN Design Therapeutics	12/9/2022	Target Lowered by	SVB Leerink		Outperform	$30.00 -> $22.00	Low

PHR Phreesia	12/9/2022	Upgraded by	SVB Leerink	Analyst Stephanie Davis	Market Perform -> Outperform	$31.00 -> $34.00	Low
MRTX Mirati Therapeutics	12/8/2022	Target Lowered by	SVB Leerink		Outperform	$102.00 -> $85.00	Low
REPL Replimune Group	12/7/2022	Target Raised by	SVB Leerink		Outperform	$30.00 -> $34.00	Low
GOSS Gossamer Bio	12/7/2022	Target Lowered by	SVB Leerink		Outperform	$15.00 -> $10.00	Low
RCKT Rocket Pharmaceuticals	12/6/2022	Target Lowered by	SVB Leerink		Outperform	$56.00 -> $54.00	Low
VEEV Veeva Systems	12/2/2022	Target Lowered by	SVB Leerink		Outperform	$242.00 -> $233.00	Low
NTLA Intellia Therapeutics	12/2/2022	Target Lowered by	SVB Leerink		Outperform	$90.00 -> $86.00	Low
LNTH Lantheus	11/30/2022	Initiated by	SVB Leerink		Outperform		Low
PNT POINT Biopharma Global	11/30/2022	Initiated by	SVB Leerink	Analyst Faisal Khurshid	Outperform	$14.00	Low
FUSN Fusion Pharmaceuticals	11/30/2022	Initiated by	SVB Leerink	Analyst Faisal Khurshid	Outperform	$6.00	Low
OABI OmniAb	11/29/2022	Initiated by	SVB Leerink	Analyst Puneet Souda	Outperform	$6.00	Low
AXSM Axsome Therapeutics	11/29/2022	Target Raised by	SVB Leerink		Outperform	$65.00 -> $85.00	Low
ARWR Arrowhead Pharmaceuticals	11/29/2022	Target Lowered by	SVB Leerink		Market Perform	$33.00 -> $31.00	Low
FATE Fate Therapeutics	11/24/2022	Target Set by	SVB Leerink			$64.00	Low
ACLX Arcellx	11/24/2022	Target Lowered by	SVB Leerink			$35.00	Low
TRVI Trevi Therapeutics	11/22/2022	Initiated by	SVB Leerink	Analyst T. Smith	Outperform	$6.00	Low
ARVN Arvinas	11/22/2022	Target Lowered by	SVB Leerink		Outperform	$89.00 -> $74.00	Low
SGRY Surgery Partners	11/22/2022	Target Lowered by	SVB Leerink	Analyst W. Mayo	Outperform	$55.00 -> $40.00	Low
A Agilent Technologies	11/22/2022	Target Raised by	SVB Leerink		Outperform	$145.00 -> $160.00	Low
ALPN Alpine Immune Sciences	11/21/2022	Initiated by	SVB Leerink	Analyst T. Smith	Outperform	$15.00	Low
TWST Twist Bioscience	11/21/2022	Target Lowered by	SVB Leerink		Market Perform	$45.00 -> $30.00	Low
PRVB Provention Bio	11/21/2022	Target Raised by	SVB Leerink		Outperform	$16.00 -> $19.00	Low
EDIT Editas Medicine	11/17/2022	Target Lowered by	SVB Leerink	Analyst R. Bienkowski	Market Perform	$14.00 -> $7.00	Low
TBPH Theravance Biopharma	11/17/2022	Target Raised by	SVB Leerink		Outperform	$12.00 -> $14.00	Low
COGT Cogent Biosciences	11/17/2022	Target Lowered by	SVB Leerink		Outperform	$20.00 -> $18.00	Low
OLK Olink Holding AB (publ)	11/15/2022	Target Raised by	SVB Leerink		Outperform	$25.00 -> $27.00	Low
LNTH Lantheus	11/15/2022	Target Raised by	SVB Leerink		Outperform	$110.00 -> $120.00	Low
IPHA Innate Pharma	11/15/2022	Target Lowered by	SVB Leerink		Outperform	$10.00 -> $9.00	Low
ROIV Roivant Sciences	11/15/2022	Target Raised by	SVB Leerink		Outperform	$7.00 -> $8.00	Low
STSA Satsuma Pharmaceuticals	11/15/2022	Downgraded by	SVB Leerink	Analyst M. Goodman	Outperform -> Market Perform		Low
MASS 908 Devices	11/15/2022	Target Lowered by	SVB Leerink		Outperform	$30.00 -> $25.00	Low
HARP Harpoon Therapeutics	11/15/2022	Target Lowered by	SVB Leerink		Outperform	$10.00 -> $4.00	Low
ASND Ascendis Pharma A/S	11/14/2022	Target Lowered by	SVB Leerink		Outperform	$168.00 -> $148.00	Low
AIRS AirSculpt Technologies	11/14/2022	Target Lowered by	SVB Leerink		Outperform	$27.00 -> $8.00	Low
HALO Halozyme Therapeutics	11/14/2022	Target Raised by	SVB Leerink		Outperform	$52.00 -> $62.00	Low
IFRX InflaRx	11/9/2022	Reiterated by	SVB Leerink	Analyst J. Schwartz	Outperform		Low
PRVA Privia Health Group	11/11/2022	Target Lowered by	SVB Leerink		Outperform	$46.00 -> $39.00	Low
PEPG PepGen	11/10/2022	Target Lowered by	SVB Leerink	Analyst J. Schwartz	Outperform	$40.00 -> $33.00	Low
FDMT 4D Molecular Therapeutics	11/10/2022	Target Raised by	SVB Leerink	Analyst M. Foroohar	Market Perform	$10.00 -> $11.00	Low
GMAB Genmab A/S	11/10/2022	Target Raised by	SVB Leerink		Market Perform	$33.00	Low
ARWR Arrowhead Pharmaceuticals	11/10/2022	Target Raised by	SVB Leerink		Market Perform	$32.00 -> $33.00	Low
MREO Mereo BioPharma Group	11/10/2022	Target Lowered by	SVB Leerink		Outperform	$8.00 -> $4.00	Low
IONS Ionis Pharmaceuticals	11/10/2022	Target Lowered by	SVB Leerink		Market Perform	$30.00 -> $26.00	Low
BGNE BeiGene	11/10/2022	Target Raised by	SVB Leerink		Outperform	$200.00 -> $210.00	Low
SCPH scPharmaceuticals	11/10/2022	Target Raised by	SVB Leerink	Analyst R. Ruiz	Outperform	$11.00 -> $12.00	Low
AHCO AdaptHealth	11/10/2022	Target Raised by	SVB Leerink	Analyst Whit Mayo	Outperform	$29.00 -> $30.00	Low
SGRY Surgery Partners	11/10/2022	Target Lowered by	SVB Leerink	Analyst W. Mayo	Outperform	$57.00 -> $55.00	Low
ZNTL Zentalis Pharmaceuticals	11/10/2022	Target Lowered by	SVB Leerink		Outperform	$42.00 -> $27.00	Low
ACRS Aclaris Therapeutics	11/8/2022	Reiterated by	SVB Leerink	Analyst T. Smith	Outperform		Low
NEO NeoGenomics	11/9/2022	Target Raised by	SVB Leerink		Outperform	$12.00 -> $15.00	Low

RCM R1 RCM	11/9/2022	Target Lowered by	SVB Leerink		Outperform	$35.00 -> $16.00	Low
TALK Talkspace	11/9/2022	Target Lowered by	SVB Leerink		Market Perform	$2.00 -> $1.00	Low
ABCL AbCellera Biologics	11/9/2022	Target Raised by	SVB Leerink		Outperform	$13.00 -> $20.00	Low
QTRX Quanterix	11/9/2022	Target Raised by	SVB Leerink	Analyst P. Souda	Market Perform	$12.00 -> $15.00	Low
HCAT Health Catalyst	11/9/2022	Target Lowered by	SVB Leerink		Outperform	$20.00 -> $17.00	Low
MRTX Mirati Therapeutics	11/9/2022	Target Lowered by	SVB Leerink		Outperform	$111.00 -> $102.00	Low
MNKD MannKind	11/9/2022	Target Raised by	SVB Leerink		Outperform	$5.00 -> $6.00	Low
NVTA Invitae	11/9/2022	Target Raised by	SVB Leerink	Analyst P. Souda	Market Perform	$2.50 -> $3.00	Low
HIMS Hims & Hers Health	11/8/2022	Upgraded by	SVB Leerink	Analyst J. Zhang	Market Perform -> Outperform	$5.00	Low
TSVT 2seventy bio	11/8/2022	Target Lowered by	SVB Leerink		Outperform	$42.00 -> $41.00	Low
CLOV Clover Health Investments	11/8/2022	Target Lowered by	SVB Leerink		Market Perform	$3.00 -> $1.50	Low
CI The Cigna Group	11/8/2022	Target Raised by	SVB Leerink		Market Perform	$305.00 -> $335.00	Low
AMTI Applied Molecular Transport	11/8/2022	Target Lowered by	SVB Leerink		Outperform	$21.00 -> $15.00	Low
BEAM Beam Therapeutics	11/7/2022	Target Lowered by	SVB Leerink		Outperform	$82.00 -> $81.00	Low
ELEV Elevation Oncology	11/7/2022	Downgraded by	SVB Leerink	Analyst A. Berens	Outperform -> Market Perform	$11.00 -> $2.00	Low
ALNY Alnylam Pharmaceuticals	11/7/2022	Target Raised by	SVB Leerink		Market Perform	$142.00 -> $145.00	Low
ALVR AlloVir	11/7/2022	Target Raised by	SVB Leerink		Outperform	$24.00 -> $25.00	Low
CRSP CRISPR Therapeutics	11/7/2022	Target Raised by	SVB Leerink		Outperform	$75.00 -> $76.00	Low
IMVT Immunovant	11/4/2022	Target Raised by	SVB Leerink		Outperform	$12.00 -> $14.00	Low
MRUS Merus	11/4/2022	Target Lowered by	SVB Leerink		Outperform	$39.00 -> $35.00	Low
RGNX REGENXBIO	11/4/2022	Target Raised by	SVB Leerink		Market Perform	$13.00 -> $14.00	Low
KPTI Karyopharm Therapeutics	11/4/2022	Target Raised by	SVB Leerink		Market Perform	$5.00 -> $6.00	Low
AUPH Aurinia Pharmaceuticals	11/4/2022	Target Lowered by	SVB Leerink		Outperform	$17.00 -> $12.00	Low
MD Pediatrix Medical Group	11/4/2022	Target Lowered by	SVB Leerink		Market Perform	$20.00 -> $16.00	Low
VIR Vir Biotechnology	11/4/2022	Target Raised by	SVB Leerink	Analyst R. Ruiz	Outperform	$40.00 -> $45.00	Low
REGN Regeneron Pharmaceuticals	11/4/2022	Target Raised by	SVB Leerink	Analyst D. Risinger	Market Perform	$756.00 -> $770.00	Low
AGL agilon health	11/4/2022	Target Lowered by	SVB Leerink		Outperform	$33.00 -> $30.00	Low
CYRX Cryoport	11/4/2022	Target Lowered by	SVB Leerink		Outperform	$45.00 -> $28.00	Low
PFE Pfizer	11/3/2022	Target Raised by	SVB Leerink	Analyst David Risinger	Market Perform	$48.00 -> $49.00	Low
RARE Ultragenyx Pharmaceutical	11/3/2022	Target Lowered by	SVB Leerink		Outperform	$115.00 -> $108.00	Low
RCUS Arcus Biosciences	11/3/2022	Target Lowered by	SVB Leerink		Outperform	$40.00 -> $38.00	Low
HUM Humana	11/3/2022	Target Raised by	SVB Leerink		Outperform	$540.00 -> $640.00	Low
VCYT Veracyte	11/3/2022	Target Raised by	SVB Leerink		Outperform	$30.00 -> $35.00	Low
OMCL Omnicell	11/3/2022	Target Lowered by	SVB Leerink	Analyst J. Zhang	Market Perform	$117.00 -> $54.00	N/A
HZNP Horizon Therapeutics Public	11/3/2022	Target Raised by	SVB Leerink	Analyst D. Risinger	Outperform	$80.00 -> $88.00	Low
EDIT Editas Medicine	11/3/2022	Target Lowered by	SVB Leerink		Market Perform	$14.00 -> $12.00	Low
ALGS Aligos Therapeutics	11/3/2022	Target Lowered by	SVB Leerink	Analyst R. Ruiz	Market Perform	$3.00 -> $2.00	Low
LLY Eli Lilly and	11/2/2022	Target Raised by	SVB Leerink		Outperform	$341.00 -> $384.00	Low
BPMC Blueprint Medicines	11/2/2022	Target Lowered by	SVB Leerink	Analyst A. Berens	Market Perform	$57.00 -> $52.00	Low
WAT Waters	11/2/2022	Target Raised by	SVB Leerink		Market Perform	$310.00 -> $320.00	Low
TECH Bio-Techne	11/2/2022	Target Lowered by	SVB Leerink		Outperform	$137.50 -> $125.00	Low
NBIX Neurocrine Biosciences	11/2/2022	Target Raised by	SVB Leerink		Market Perform	$100.00 -> $115.00	Low
MYGN Myriad Genetics	11/2/2022	Target Lowered by	SVB Leerink		Market Perform	$27.00 -> $25.00	Low
AMED Amedisys	11/1/2022	Target Lowered by	SVB Leerink		Market Perform	$116.00 -> $96.00	Low
GILD Gilead Sciences	11/1/2022	Target Raised by	SVB Leerink	Analyst D. Risinger	Market Perform	$68.00 -> $81.00	Low
MRK Merck & Co., Inc.	10/28/2022	Target Raised by	SVB Leerink		Outperform	$110.00 -> $112.00	Low
ARGX argenx	10/28/2022	Target Raised by	SVB Leerink	Analyst T. Smith	Outperform	$428.00 -> $430.00	Low
CCCC C4 Therapeutics	10/26/2022	Reiterated by	SVB Leerink	Analyst C. Liu	Outperform		Low
INSM Insmed	10/27/2022	Target Lowered by	SVB Leerink		Outperform	$52.00 -> $50.00	Low
UHS Universal Health Services	10/27/2022	Target Raised by	SVB Leerink		Market Perform	$98.00 -> $114.00	Low
TMO Thermo Fisher Scientific	10/27/2022	Target Lowered by	SVB Leerink		Outperform	$590.00 -> $555.00	Low
WVE Wave Life Sciences	10/24/2022	Reiterated by	SVB Leerink	Analyst M. Foroohar	Market Perform		Low
NXGN NextGen Healthcare	10/26/2022	Target Raised by	SVB Leerink		Outperform	$24.00 -> $25.00	Low
BIIB Biogen	10/26/2022	Target Raised by	SVB Leerink		Outperform	$270.00 -> $310.00	Low
RXRX Recursion Pharmaceuticals	10/25/2022	Target Lowered by	SVB Leerink		Market Perform	$10.00 -> $9.00	Low
THC Tenet Healthcare	10/25/2022	Target Lowered by	SVB Leerink	Analyst Whit Mayo	Outperform	$89.00 -> $55.00	Low
HCA HCA Healthcare	10/24/2022	Target Lowered by	SVB Leerink		Outperform	$252.00 -> $238.00	Low
STOK Stoke Therapeutics	10/24/2022	Upgraded by	SVB Leerink	Analyst Rudy Li	Market Perform -> Outperform	$30.00	Low
ZYME Zymeworks	10/21/2022	Downgraded by	SVB Leerink	Analyst A. Berens	Outperform -> Market Perform	$19.00 -> $8.00	Low
IMUX Immunic	10/21/2022	Downgraded by	SVB Leerink	Analyst Thomas Smith	Outperform -> Market Perform	$9.00 -> $5.00	Low

MarketBeat Community Rating for SVB Leerink

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		20,204 (Vote Outperform)
Underperform Votes:		16,831 (Vote Underperform)
Total Votes:		37,035

MarketBeat's community ratings are surveys of what our community members think about SVB Leerink and other research firms. Vote "Outperform" if you believe SVB Leerink's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SVB Leerink's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

SVB Leerink Analyst Recommendations & Stock Picks

MarketBeat Community Rating for SVB Leerink

Stock Ratings Reports and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info